Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Magnolia and Phellodendron (Magnolia Officinalis and Phellodendron Amurense) Bark Extracts on Anxiety, Cognitive Performance, and Mood Tested After Induced Stress

NCT02734251 is registered in ClinicalTrials.gov with InterHealth Nutraceuticals, Inc. as lead sponsor.

NCT NCT02734251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02734251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Magnolia and Phellodendron (Magnolia Officinalis and Phellodendron Amurense) Bark Extracts on Anxiety, Cognitive Performance, and Mood Tested After Induced Stress
Lead sponsor
InterHealth Nutraceuticals, Inc.
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2016
Completion date
Not reported
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mood (psychological function)